NCCS supports a prescription drug benefit through Medicare Part B for all FDA approved Intravenous (IV) and oral anti-cancer agents. This benefit should include new agents without IV ...
... of oral cancer drugs that have an injectable equivalent. However, Medicare does not pay for oral anti-cancer ... enacted immediately and implemented promptly. This will provide vital cancer drug ...
Letter To All Medicare Conferees Urging Oral Cancer Drug Transition Benefit (September 24, 2003) CLC Hails Introduction of Access to Cancer Therapies Act in 108th Congress
Medicare Non-Coverage of New Oral Cancer Treatments: A Hard Pill To Swallow Promising new drugs are revolutionizing ... leaders would prefer that the legislation be part of a comprehensive Medicare drug ...